Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 8-9, Août–Septembre 2013
Page(s) 722 - 728
Section Diabète : approches thérapeutiques émergentes
DOI https://doi.org/10.1051/medsci/2013298010
Publié en ligne 5 septembre 2013
  1. Lehuen A, Diana J, Zaccone P, Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010 ; 10 : 501–513. [CrossRef] [PubMed] [Google Scholar]
  2. Diana J, Simoni Y, Furio L, et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 2013 ; 19 : 65–73. [CrossRef] [PubMed] [Google Scholar]
  3. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007 ; 25 : 297–336. [CrossRef] [PubMed] [Google Scholar]
  4. Simoni Y, Diana J, Ghazarian L, et al. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clin Exp Immunol 2013 ; 171 : 8–19. [CrossRef] [PubMed] [Google Scholar]
  5. Gombert JM, Herbelin A, Tancrede-Bohin E, et al. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol 1996 ; 26 : 2989–2998. [CrossRef] [PubMed] [Google Scholar]
  6. Hammond KJ, Pellicci DG, Poulton LD, et al. CD1d-restricted NKT cells: an interstrain comparison. J Immunol 2001 ; 167 : 1164–1173. [PubMed] [Google Scholar]
  7. Lehuen A, Lantz O, Beaudoin L, et al. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998 ; 188 : 1831–1839. [CrossRef] [PubMed] [Google Scholar]
  8. Falcone M, Facciotti F, Ghidoli N, et al. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J Immunol 2004 ; 172 : 5908–5916. [PubMed] [Google Scholar]
  9. Wang B, Geng YB, Wang CR. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J Exp Med 2001 ; 194 : 313–320. [CrossRef] [PubMed] [Google Scholar]
  10. Shi FD, Flodstrom M, Balasa B, et al. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc Natl Acad Sci USA 2001 ; 98 : 6777–6782. [CrossRef] [Google Scholar]
  11. Rapoport MJ, Jaramillo A, Zipris D, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993 ; 178 : 87–99. [CrossRef] [PubMed] [Google Scholar]
  12. Laloux V, Beaudoin L, Jeske D, et al. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J Immunol 2001 ; 166 : 3749–3756. [PubMed] [Google Scholar]
  13. Hammond KJ, Poulton LD, Palmisano LJ, et al. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998 ; 187 : 1047–1056. [CrossRef] [PubMed] [Google Scholar]
  14. Chen YG, Choisy-Rossi CM, Holl TM, et al. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J Immunol 2005 ; 174 : 1196–1204. [PubMed] [Google Scholar]
  15. Beaudoin L, Laloux V, Novak J, et al. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 2002 ; 17 : 725–736. [CrossRef] [PubMed] [Google Scholar]
  16. Naumov YN, Bahjat KS, Gausling R, et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci USA 2001 ; 98 : 13838–13843. [CrossRef] [Google Scholar]
  17. Novak J, Beaudoin L, Park S. Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression. J Immunol 2007 ; 178:1332–1340. [PubMed] [Google Scholar]
  18. Novak J, Beaudoin L, Griseri T, Lehuen A. Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J Immunol 2005 ; 174 : 1954–1961. [PubMed] [Google Scholar]
  19. Michel ML, Keller AC, Paget C, et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007 ; 204 : 995–1001. [CrossRef] [PubMed] [Google Scholar]
  20. Simoni Y, Gautron AS, Beaudoin L, et al. NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes. Eur J Immunol 2011 ; 41 : 3574–3585. [CrossRef] [PubMed] [Google Scholar]
  21. Wilson SB, Kent SC, Patton KT, et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998 ; 391 : 177–181. [CrossRef] [PubMed] [Google Scholar]
  22. Kis J, Engelmann P, Farkas K, et al. Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus. J Leukoc Biol 2007 ; 81 : 654–662. [CrossRef] [PubMed] [Google Scholar]
  23. Kent SC, Chen Y, Clemmings SM, et al. Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells. J Immunol 2005 ; 175 : 4458–4464. [PubMed] [Google Scholar]
  24. Diana J, Brezar V, Beaudoin L, et al. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J Exp Med 2011 ; 208 : 729–745. [CrossRef] [PubMed] [Google Scholar]
  25. Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988 ; 239 : 500–502. [CrossRef] [PubMed] [Google Scholar]
  26. Diana J, Griseri T, Lagaye S, et al. NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity 2009 ; 30 : 289–299. [CrossRef] [PubMed] [Google Scholar]
  27. Sharif S, Arreaza GA, Zucker P, et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001 ; 7 : 1057–1062. [CrossRef] [PubMed] [Google Scholar]
  28. Wang J, Cho S, Ueno A, et al. Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation. J Immunol 2008 ; 181 : 2438–2445. [PubMed] [Google Scholar]
  29. Blumenfeld HJ, Tohn R, Haeryfar SM, et al. Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice. Clin Exp Immunol 2011 ; 166 : 121–133. [CrossRef] [PubMed] [Google Scholar]
  30. Ghazarian L, Diana J, Simoni Y, et al. Prevention or acceleration of type 1 diabetes by viruses. Cell Mol Life Sci 2013 ; 70 : 239–255. [CrossRef] [PubMed] [Google Scholar]
  31. Motohashi S, Ishikawa A, Ishikawa E, et al. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2006 ; 12 : 6079–6086. [CrossRef] [PubMed] [Google Scholar]
  32. Brennan PJ, Tatituri RV, Brigl M, et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011 ; 12 : 1202–1211. [CrossRef] [PubMed] [Google Scholar]
  33. Hegde S, Lockridge JL, Becker YA, et al. Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands. J Autoimmun 2011 ; 37 : 28–28. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.